AstraZeneca made roughly $10 billion offer for obesity drugmaker Rhythm Pharmaceuticals
The reported bid would deepen AstraZeneca's push into the obesity and metabolic disease market.
Read at WSJ →Full coverage · 15 outlets
- WSJ · lead
- ReutersAstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say
- U.S. NewsAstraZeneca Made $10 Billion Offer for Obesity Drugmaker Rhythm, Sources Say
- WHBL NewsAstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say
- FinimizeAstraZeneca Weighed A $10 Billion Bid For Rhythm
- Yahoo Finance SingaporeAstraZeneca made $10 billion bid for obesity drugmaker Rhythm, WSJ reports
- BigGo FinanceAstraZeneca Weighs Roughly $10 Billion Takeover of Rhythm Pharmaceuticals, Sending Shares Up 28%
- investingLiveAstraZeneca makes $10 billion offer for obesity drugmaker Rhythm, WSJ reports
- 1470 & 100.3 WMBDAstraZeneca made $10 billion bid for obesity drugmaker Rhythm, WSJ reports
- DealroomReports: AstraZeneca makes ~$10B offer for rare-obesity drugmaker Rhythm Pharmaceuticals
- FirstWord PharmaAstraZeneca reportedly bid $10B to buy Rhythm
- DevdiscourseReuters Health News Summary
- TradingViewAstraZeneca made $10 billion bid for obesity drugmaker Rhythm, WSJ reports
- Yahoo FinanceRYTM Stock Clocks Best Day In Nearly 16 Months On AstraZeneca $10B Bid Report
- Yahoo Finance UKRhythm Pharmaceuticals stock surges 28% on AstraZeneca bid report